Clinical trial
A Prospective Cohort Study of Unplanned Hospitalization and Emergency Department Use in Patients With Head and Neck Cancer Receiving Radiotherapy: Incidence, Factors and Development of a Risk Prediction Model
NCT07929194 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Cohort Study of Unplanned Hospitalization and Emergency Department Use in Patients With Head and Neck Cancer Receiving Radiotherapy: Incidence, Factors and Development of a Risk Prediction Model
- Lead sponsor
- Xiangya Hospital of Central South University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- August 12, 2028
- Enrollment
- 657 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
HNC Patients Receiving IMRT
Consecutive adults with histologically confirmed head and neck cancer scheduled for intensity-modulated radiotherapy (IMRT/VMAT), with or without concurrent chemotherapy or targeted therapy, enrolled before radiotherapy and followed from the first treatment fraction through 30 days after treatment completion. No study-assigned intervention is provided; all patients receive standard clinical care.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Incidence of Unplanned Hospitalization
Proportion of participants with at least one unplanned inpatient admission, defined as any unscheduled inpatient admission encompassing (i) outpatient-to-inpatient transfer during radiotherapy, (ii) emergency department-led admission, and (iii) readmission after treatment discharge; planned elective admissions are excluded.
Lead sponsor's other trials
Xiangya Hospital of Central South University, most recent start first.
+169 more trials
Similar trials
Same condition (Head and Neck Neoplasms) and phase, most recent start first.
+514 more trials See the condition page